Epigenetic Target HDAC5 Reduces Environment-Triggered Cocaine Seeking in Rats

Managing stimulant use disorders remains a profound clinical challenge, characterized by frequent relapse and an average treatment dropout rate of 30.4% (95% confidence interval, 27.2 to 33.8) across psychosocial interventions [1]. While pharmacological interventions such as prescription psychostimulants increase sustained abstinence rates (relative risk 1.45; 95% confidence interval, 1.10 to 1.92) [2], and therapies like glucagon-like peptide-1 receptor agonists show utility in reducing drug consumption in preclinical models [3, 4], long-term recovery is notoriously difficult to maintain. A major driver of this recurrent cycle is the powerful associative memory linking specific environments to past drug use, which can trigger intense cravings even after prolonged periods of recovery. Functional magnetic resonance imaging (MRI) studies consistently point to dysregulation in prefrontal cortical circuits, specifically the lateral prefrontal cortex and dorsal anterior cingulate cortex, as a core feature of this context reactivity that fundamentally undermines a patient's inhibitory control [5, 6]. Now, a preclinical study details the specific epigenetic mechanisms (changes in gene expression that do not alter the underlying DNA sequence) within the prefrontal cortex that govern these environmental relapse triggers, identifying specific pathways that could eventually serve as pharmacological targets to prevent cue-induced relapse in patients.